Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Innoviva (INVA) Forecast
NewsEarningsInnoviva (INVA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Innoviva (NASDAQ:INVA) Stock Quotes, Forecast and News Summary
Innoviva Stock (NASDAQ: INVA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Innoviva (INVA) stock?
You can purchase shares of Innoviva (NASDAQ:INVA) through any online brokerage.
Who are Innoviva (INVA) competitors?
Other companies in Innoviva’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Xeris Biopharma Holdings (NASDAQ:XERS), Phibro Animal Health (NASDAQ:PAHC), Rapport Therapeutics (NASDAQ:RAPP) and Neumora Therapeutics (NASDAQ:NMRA).
What is the forecast, or price target, for Innoviva (INVA) stock?
Innoviva has a consensus price target of $15.17.
What is the current price for Innoviva (INVA)?
The stock price for Innoviva (NASDAQ: INVA) is $18 last updated December 20, 2024 at 4:02 PM EST.
Does Innoviva (INVA) pay a dividend?
There are no upcoming dividends for Innoviva.
When is Innoviva (NASDAQ:INVA) reporting earnings?
Innoviva’s Q4 earnings are confirmed for Thursday, February 27, 2025.
Is Innoviva (INVA) going to split?
There is no upcoming split for Innoviva.
What sector and industry does Innoviva (INVA) operate in?
Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.